UA115671C2 - Нікотинова композиція - Google Patents

Нікотинова композиція

Info

Publication number
UA115671C2
UA115671C2 UAA201502760A UAA201502760A UA115671C2 UA 115671 C2 UA115671 C2 UA 115671C2 UA A201502760 A UAA201502760 A UA A201502760A UA A201502760 A UAA201502760 A UA A201502760A UA 115671 C2 UA115671 C2 UA 115671C2
Authority
UA
Ukraine
Prior art keywords
glycol
nicotine composition
nicotine
monohydric alcohol
glycol ether
Prior art date
Application number
UAA201502760A
Other languages
English (en)
Inventor
Алекс Хірн
Стюарт Бхімсен Лоу
Рітіка Гупта
Кріс Мойзес
Original Assignee
Кінд Консумер Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Кінд Консумер Лімітед filed Critical Кінд Консумер Лімітед
Publication of UA115671C2 publication Critical patent/UA115671C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10—Chemical features of tobacco products or tobacco substitutes
    • A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20—Devices without heating means
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60—Constructional details
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F47/00—Smokers' requisites not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0091—Inhalators mechanically breath-triggered
    • A61M15/0093—Inhalators mechanically breath-triggered without arming or cocking, e.g. acting directly on the delivery valve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F15/00—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor
    • A24F15/01—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor
    • A24F15/015—Receptacles or boxes specially adapted for cigars, cigarettes, simulated smoking devices or cigarettes therefor specially adapted for simulated smoking devices or cigarettes therefor with means for refilling of liquid inhalable precursors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A61M2209/04—Tools for specific apparatus
    • A61M2209/045—Tools for specific apparatus for filling, e.g. for filling reservoirs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Otolaryngology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

Інгальована композиція, яка включає: нікотин або його фармацевтично прийнятну похідну або його сіль; газ-витиснювач; одноатомний спирт; гліколь та/або глікольефір, яка відрізняється тим, що відношення одноатомний спирт:гліколь або глікольефір за масою знаходиться в межах від 6:1 до 1:1.
UAA201502760A 2012-08-28 2013-08-23 Нікотинова композиція UA115671C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1215273.2A GB201215273D0 (en) 2012-08-28 2012-08-28 Nicotine composition
PCT/GB2013/052231 WO2014033437A2 (en) 2012-08-28 2013-08-23 Nicotine composition

Publications (1)

Publication Number Publication Date
UA115671C2 true UA115671C2 (uk) 2017-12-11

Family

ID=47045483

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201502760A UA115671C2 (uk) 2012-08-28 2013-08-23 Нікотинова композиція

Country Status (25)

Country Link
US (1) US9655890B2 (uk)
EP (1) EP2890256B1 (uk)
JP (1) JP6185067B2 (uk)
KR (1) KR102256326B1 (uk)
CN (1) CN104768406B (uk)
AR (1) AR092261A1 (uk)
AU (1) AU2013308229B2 (uk)
BR (1) BR112015004231B1 (uk)
CA (1) CA2883379C (uk)
CL (1) CL2015000486A1 (uk)
DK (1) DK2890256T3 (uk)
ES (1) ES2902996T3 (uk)
GB (1) GB201215273D0 (uk)
HK (1) HK1211188A1 (uk)
IL (1) IL237467B (uk)
IN (1) IN2015DN02328A (uk)
MX (1) MX2015002476A (uk)
NZ (1) NZ706361A (uk)
PH (1) PH12015500686A1 (uk)
PL (1) PL2890256T3 (uk)
RU (1) RU2662550C2 (uk)
TW (1) TWI612979B (uk)
UA (1) UA115671C2 (uk)
WO (1) WO2014033437A2 (uk)
ZA (1) ZA201502013B (uk)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160345631A1 (en) 2005-07-19 2016-12-01 James Monsees Portable devices for generating an inhalable vapor
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
US10638792B2 (en) 2013-03-15 2020-05-05 Juul Labs, Inc. Securely attaching cartridges for vaporizer devices
GB2514758B (en) 2013-03-26 2015-06-24 Kind Consumer Ltd A Pressurised Refill Canister with an Outlet Valve
GB2512325B (en) 2013-03-26 2016-06-22 Kind Consumer Ltd A pressurised refill canister with an outlet valve
GB2512326B (en) 2013-03-26 2016-02-24 Kind Consumer Ltd A pressurised refill canister with an outlet valve
MY179801A (en) * 2013-07-19 2020-11-16 Altria Client Services Llc Liquid aerosol formulation of an electronic smoking article
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
HUE053511T2 (hu) 2013-12-23 2021-07-28 Juul Labs Int Inc Párologtató eszközt tartalmazó rendszer
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
GB2524469A (en) 2014-02-14 2015-09-30 Kind Consumer Ltd A cannabinoid inhaler and composition therefor
GB2524293B (en) 2014-03-19 2017-12-06 Kind Consumer Ltd An inhaler
CN105828819A (zh) * 2014-04-08 2016-08-03 桑萨（巴巴多斯）公司 烟碱制剂及其制备方法
US9738622B2 (en) * 2014-05-27 2017-08-22 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
US10508096B2 (en) 2014-05-27 2019-12-17 R.J. Reynolds Tobacco Company Nicotine salts, co-crystals, and salt co-crystal complexes
GB2528434A (en) * 2014-06-26 2016-01-27 Kind Consumer Ltd Nicotine dosage regimen
CN107072313A (zh) * 2014-06-25 2017-08-18 亲切消费者有限公司 烟碱剂量方案
GB2530980A (en) * 2014-09-19 2016-04-13 Kind Consumer Ltd Simulated cigarette
CA2969728C (en) 2014-12-05 2023-06-13 Pax Labs, Inc. Calibrated dose control
CN105054281B (zh) * 2015-07-21 2016-11-23 中国烟草总公司广东省公司 一种气雾型口香烟
US9585835B1 (en) * 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US11224594B2 (en) * 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
US10149844B2 (en) 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
GB2542389A (en) * 2015-09-17 2017-03-22 Kind Consumer Ltd Simulated cigarette
GB2542404B (en) * 2015-09-18 2019-08-14 Kind Consumer Ltd An inhalable composition and an inhaler
GB201516729D0 (en) * 2015-09-22 2015-11-04 The Technology Partnership Plc Liquid nicotine formulation
CN114656446A (zh) * 2015-11-25 2022-06-24 R.J.雷诺兹烟草公司 烟碱盐、共晶体和盐共晶体配合物
CN105455190A (zh) * 2016-02-01 2016-04-06 湖北中烟工业有限责任公司 一种电子烟液
MX2018009702A (es) 2016-02-11 2019-07-08 Juul Labs Inc Cartucho rellenable de vaporizador y metodo de relleno.
JP2019512470A (ja) * 2016-02-29 2019-05-16 ニコゲン リミテッド ニコチン配合物及びエアロゾル
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD848057S1 (en) 2016-06-23 2019-05-07 Pax Labs, Inc. Lid for a vaporizer
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
WO2019198162A1 (ja) * 2018-04-10 2019-10-17 日本たばこ産業株式会社 霧化ユニット
KR20210024482A (ko) 2018-06-28 2021-03-05 필립모리스 프로덕츠 에스.에이. 액체 알칼로이드 제형을 포함하는 알칼로이드 공급원을 포함하는 에어로졸 발생 시스템용 카트리지
EP3826705B1 (en) 2018-07-23 2022-09-14 Juul Labs, Inc. Airflow management for vaporizer device
GB201817867D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201817863D0 (en) * 2018-11-01 2018-12-19 Nicoventures Trading Ltd Aerosolisable formulation
GB201821088D0 (en) * 2018-12-21 2019-02-06 Nicoventures Trading Ltd Vaping monitor system and method
US11541004B2 (en) 2020-06-10 2023-01-03 Howard University Method for treating or mitigating Parkinson's disease using nicotine inhaler or nicotine nasal spray
USD1028336S1 (en) 2021-06-22 2024-05-21 Pax Labs, Inc. Vaporizer cartridge
IT202100027086A1 (it) * 2021-10-21 2023-04-21 Alberto Patarchi Erogatore portatile per il trattamento o la prevenzione di un’infezione o di una patologia causata da un virus
WO2023154983A1 (en) * 2022-02-18 2023-08-24 Inhaler Supplies Pty Ltd Nicotine formulation
WO2023157208A1 (ja) * 2022-02-18 2023-08-24 日本たばこ産業株式会社 たばこ製品、非燃焼性加熱型香味吸引器具、たばこ製品の製造方法
CN115813006B (zh) * 2022-09-05 2023-08-18 东莞市鸿馥生物科技有限公司 一种能够提高果香的电子烟液及其制备方法
KR20240049697A (ko) 2022-10-07 2024-04-17 주식회사 케이티앤지 에어로졸 흡입기용 액상 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1017032A (en) * 1963-12-12 1966-01-12 Aerosmoke Ltd Aerosol compositions
JPS63148973A (ja) * 1987-07-08 1988-06-21 大日精化工業株式会社 かぎ煙草
US6413496B1 (en) * 1996-12-04 2002-07-02 Biogland Ireland (R&D) Limited Pharmaceutical compositions and devices for their administration
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
CN101084801A (zh) 2003-04-29 2007-12-12 韩力 一种非可燃性电子喷雾香烟
WO2006004646A1 (en) * 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
GB0712308D0 (en) 2007-06-25 2007-08-01 Kind Group Ltd An inhalable composition
US20110213021A1 (en) * 2008-03-04 2011-09-01 Indigene Pharmaceuticals, Inc. Compositions and methods for treating nos-associated diseases
GB0808154D0 (en) * 2008-05-06 2008-06-11 British American Tobacco Co Aerosol dispensing device
GB0823491D0 (en) * 2008-12-23 2009-01-28 Kind Consumer Ltd A simulated cigarette device
CN102080276B (zh) * 2009-11-30 2014-05-14 合肥中科绿色家电科技有限公司 可生物降解的烟用纤维材料及香烟过滤嘴
GB201003552D0 (en) * 2010-03-03 2010-04-21 Kind Consumer Ltd A simulated cigarette
EP2460422A1 (en) * 2010-12-03 2012-06-06 Philip Morris Products S.A. An aerosol generating system with provention of condensate leakage
EP2468117A1 (en) * 2010-12-24 2012-06-27 Philip Morris Products S.A. An aerosol generating system having means for determining depletion of a liquid substrate
CN102266125B (zh) * 2011-07-28 2013-01-09 易侧位 一种中药戒烟电子烟
US8646461B2 (en) * 2011-12-14 2014-02-11 Sentiens, Llc Device and method for simulating chemosensation of smoking

Also Published As

Publication number Publication date
CN104768406B (zh) 2018-11-16
IL237467A0 (en) 2015-04-30
TW201410274A (zh) 2014-03-16
KR102256326B1 (ko) 2021-05-26
NZ706361A (en) 2018-05-25
GB201215273D0 (en) 2012-10-10
AU2013308229A1 (en) 2015-04-09
EP2890256A2 (en) 2015-07-08
US20150297580A1 (en) 2015-10-22
AR092261A1 (es) 2015-04-08
CA2883379C (en) 2016-11-15
IN2015DN02328A (uk) 2015-08-28
CL2015000486A1 (es) 2015-10-02
JP2015527071A (ja) 2015-09-17
IL237467B (en) 2018-12-31
HK1211188A1 (en) 2016-05-20
PH12015500686B1 (en) 2015-06-08
RU2662550C2 (ru) 2018-07-26
ES2902996T3 (es) 2022-03-30
EP2890256B1 (en) 2021-10-27
PH12015500686A1 (en) 2015-06-08
BR112015004231A2 (pt) 2017-07-04
RU2015110686A (ru) 2016-10-20
BR112015004231B1 (pt) 2021-06-08
PL2890256T3 (pl) 2022-02-21
WO2014033437A2 (en) 2014-03-06
JP6185067B2 (ja) 2017-08-23
CN104768406A (zh) 2015-07-08
AU2013308229B2 (en) 2019-05-09
US9655890B2 (en) 2017-05-23
KR20150046318A (ko) 2015-04-29
MX2015002476A (es) 2015-06-05
DK2890256T3 (da) 2022-01-17
TWI612979B (zh) 2018-02-01
ZA201502013B (en) 2016-10-26
CA2883379A1 (en) 2014-03-06
WO2014033437A3 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
PH12015500686A1 (en) Nicotine composition
NZ723838A (en) Cannabinoid compositions and uses
MX2015011520A (es) Composiciones antimicrobianas.
BR112015000229A2 (pt) formulações aquosas estáveis de etanercept
MX2016015179A (es) Una formulación líquida que comprende nicotina para administracion en aerosol.
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
PH12016500043A1 (en) Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-andrenergic for administration by inhalation
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
MX348823B (es) Formulaciones estables de linaclotida.
SG10201804817TA (en) Delayed release compositions of linaclotide
PH12015502118A1 (en) Pyridin-4-yl derivatives
TN2012000488A1 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016500865A1 (en) Composite formulation comprising tadalafil and amlodipine
RS53783B1 (en) INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM
MX2015005762A (es) Producto de comicronizacion que comprende acetato de ulipristal.
MY163476A (en) Oral care compositions
MX2014001621A (es) Composiciones topicas antioxidantes.
MX2014014579A (es) Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide.
MX359887B (es) Composicion masticable para administracion oral y proceso para preparar la misma.
EA032913B1 (ru) Препараты производных пиримидиндиона
MX2016000775A (es) Preparacion farmaceutica que comprende un derivado de aminopirazol.
IN2013CH04314A (uk)
WO2014115168A3 (en) Novel solvate forms of cabazitaxel and process for preparation thereof
WO2014106826A3 (en) Anthracycline analogue and uses thereof